Twitter Facebook LinkedIn YouTube

Aurora Cannibis (CSE: ACB) entered into definitive agreement to acquire Canvas Rx Inc.

Video Platform Video Management Video Solutions Video Player

Aurora Cannabis has entered into a definitive agreement to acquire CanvasRx Inc. from CanvasRx Holdings Inc. This will unite Aurora, one a Canada’s largest capacity and fastest-growing licensed producers of cannabis, with CanvasRx, Canada’s largest medical cannabis patient outreach service, which has 17 locations and more than 10,000 registered patients.

Additional Information:

Company: Aurora Cannibis
Website: http://www.auroracannibis.com
Stock Symbol: CSE: ACB
Date Published: Aug 11, 2016
Transcript: Available

Video Transcript:

I’m Tia Borden for Investmentpitch Media

Aurora Cannabis has entered into a definitive agreement to acquire CanvasRx Inc. from CanvasRx Holdings Inc. This will unite Aurora, one a Canada’s largest capacity and fastest-growing licensed producers of cannabis, with CanvasRx, Canada’s largest medical cannabis patient outreach service, which has 17 locations and more than 10,000 registered patients.

The acquisition will cost Aurora $37.5 million, the majority of which may be satisfied in cash or through the issuance of Aurora shares, at Aurora’s discretion, subject to performance milestones over a three-year period.

Aurora has also completed a brokered private place through Canaccord Genuity as well as a non-brokered private placement, for total gross proceeds of $23 million.

The 57.5 million subscription receipts, priced at $0.40, will be convertible into units, upon the satisfaction of certain escrow release conditions pertaining to the acquisition.

Each unit consists of one share and one-half a warrant, with each full warrant exercisable at $0.55 per share for two years.

Terry Booth, CEO, stated: “This financing and acquisition provide Aurora with the capital and the partner to continue to responsibly expand our position in the cannabis sector. With our industry-leading product quality and patient acquisition rate, our innovative use of technology and ultra-low cost of production, as well as our immediate plans for significant capacity expansion, Aurora is ideally placed to thrive in both the medical cannabis business and the eventual adult consumer cannabis market.”

Aurora, through its wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., operates a 55,200 square foot, expandable, state-of-the-art production facility in Mountain View County, Alberta, which is capable of producing over 8,000 kilograms of medical cannabis per year.

Plans are well advanced for the construction of a second much larger facility in Alberta.

Gross revenue for July reached a new milestone of $1 million, with sales of dried cannabis showing strong month-over-month growth.

The shares are currently trading at $0.69

For more information please visit the company’s website www.auroramj.com or contact Cam Battley, Senior VP, Communications and Medical Affairs, at 905-864-5525 or email cam@auroramj.com.

Investor relations is handled by Marc Lakmaaker at National Eqicom, who can be reached at 416-848-1397 or by email at mlakmaaker@national.ca.

I’m Tia Borden for Investmentpitch Media